HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel E Knutson Selected Research

MIDD0301

1/2021Identification and Quantification of MIDD0301 Metabolites.
12/2020Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models.
8/2020Improved scale-up synthesis and purification of clinical asthma candidate MIDD0301.
1/2020The Effects of pH on the Structure and Bioavailability of Imidazobenzodiazepine-3-Carboxylate MIDD0301.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel E Knutson Research Topics

Disease

4Asthma (Bronchial Asthma)
01/2021 - 01/2020
2Cognitive Dysfunction
06/2022 - 01/2021
2Epilepsy (Aura)
01/2022 - 01/2020
2Migraine Disorders (Migraine)
01/2021 - 01/2018
2Tics (Tic)
01/2021 - 01/2018
2Pneumonia (Pneumonitis)
12/2020 - 01/2020
2Pain (Aches)
01/2019 - 01/2018
1Schizophrenia (Dementia Praecox)
06/2022
1Postpartum Depression (Post-Natal Depression)
01/2022
1Brain Injuries (Brain Injury)
01/2022
1Post-Traumatic Epilepsy (Epilepsy, Post Traumatic)
01/2022
1Neuralgia (Stump Neuralgia)
01/2022
1Ataxia (Dyssynergia)
11/2021
1Catalepsy
01/2021
1Anxiety Disorders (Anxiety Disorder)
01/2021
1Anhedonia
01/2021
1Bronchial Spasm
12/2020
1Respiratory Hypersensitivity
12/2020
1Respiratory Insufficiency (Respiratory Failure)
12/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2019
1Mental Disorders (Mental Disorder)
04/2019
1Neurobehavioral Manifestations
04/2019

Drug/Important Bio-Agent (IBA)

4gamma-Aminobutyric Acid (GABA)IBA
06/2022 - 04/2019
4MIDD0301IBA
01/2021 - 01/2020
3Pharmaceutical PreparationsIBA
01/2021 - 01/2018
2Methamphetamine (Desoxyn)FDA LinkGeneric
06/2022 - 01/2018
2Aminobutyrates (Aminobutyric Acid)IBA
01/2022 - 01/2019
1EnzymesIBA
06/2022
1Phencyclidine (Angel Dust)IBA
06/2022
1PZ-II-029IBA
06/2022
1brexanoloneIBA
01/2022
1NeurosteroidsIBA
01/2022
1KRM-II-81IBA
01/2022
1Midazolam (Versed)FDA LinkGeneric
11/2021
1Alprazolam (Xanax)FDA LinkGeneric
11/2021
1Topiramate (Topamax)FDA LinkGeneric
01/2021
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021
1CorticosteroneIBA
01/2021
1SK&F 82958 (SKF 82958)IBA
01/2021
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Sumatriptan (Imigran)FDA LinkGeneric
01/2021
1Dopamine AntagonistsIBA
01/2021
1GABA-A Receptors (GABA(A) Receptor)IBA
01/2021
1Nitroglycerin (Dynamite)FDA LinkGeneric
01/2021
1Interferon-gamma (Interferon, gamma)IBA
12/2020
1LipopolysaccharidesIBA
12/2020
1OvalbuminIBA
12/2020
1AllergensIBA
12/2020
1Albuterol (Salbutamol)FDA LinkGeneric
12/2020
1SteroidsIBA
12/2020
1Fluticasone (Cutivate)FDA LinkGeneric
12/2020
1Methacholine Chloride (Methacholine)FDA Link
12/2020
1Biological ProductsIBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2019
1Furosemide (Lasix)FDA LinkGeneric
01/2018
1hispidulinIBA
01/2018
1FlavonoidsIBA
01/2018
1LigandsIBA
01/2018

Therapy/Procedure

2Therapeutics
06/2022 - 01/2021
1Deep Sedation
11/2021
1Injections
01/2021
1Drug Therapy (Chemotherapy)
01/2018